Pasar al contenido principal

EFECTOS PROTECTORES DEL CANNABIDIOL EN ICTUS NEONATAL Y DE ADULTO: ESTUDIO PRECLINICO DETALLADO DE LOS MECANISMOS MOLECULARES DE ACCION EN UN MODELO DE RATA

SAF2017-84117-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

N-Methyl-D-aspartate (NMDA) and cannabinoid CB receptors form functional complexes in cells of the central nervous system, insights into the therapeutic potential of neuronal and microglial NMDA receptors

  • Rivas Santisteban, Rafael|||0000-0002-2078-6819
  • Lillo, Alejandro
  • Lillo Jové, Jaume|||0000-0001-7712-0850
  • Rebassa, Joan Biel
  • Contestí, Joan S.
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Franco, Rafael|||0000-0003-2549-4919
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
The cannabinoid CB receptor (CBR), which is a target to afford neuroprotection, and N-methyl-D-aspartate (NMDA) ionotropic glutamate receptors, which are key in mediating excitatory neurotransmission, are expressed in both neurons and glia. As NMDA receptors are the target of current medication in Alzheimer's disease patients and with the aim of finding neuromodulators of their actions that could provide benefits in dementia, we hypothesized that cannabinoids could modulate NMDA function. Immunocytochemistry was used to analyze the colocalization between CB and NMDA receptors; bioluminescence resonance energy transfer was used to detect CB-NMDA receptor complexes. Calcium and cAMP determination, mitogen-activated protein kinase (MAPK) pathway activation, and label-free assays were performed to characterize signaling in homologous and heterologous systems. Proximity ligation assays were used to quantify CB-NMDA heteromer expression in mouse primary cultures and in the brain of APP transgenic mice, an Alzheimer's disease model expressing the Indiana and Swedish mutated version of the human amyloid precursor protein (APP). In a heterologous system, we identified CB-NMDA complexes with a particular heteromer print consisting of impairment by cannabinoids of NMDA receptor function. The print was detected in activated primary microglia treated with lipopolysaccharide and interferon-γ. CBR activation blunted NMDA receptor-mediated signaling in primary hippocampal neurons from APP mice. Furthermore, imaging studies showed that in brain slices and in primary cells (microglia or neurons) from APP mice, there was a marked overexpression of macromolecular CB-NMDA receptor complexes thus becoming a tool to modulate excessive glutamate input by cannabinoids. The results indicate a negative cross-talk in CB-NMDA complexes signaling. The expression of the CB-NMDA receptor heteromers increases in both microglia and neurons from the APP transgenic mice, compared with levels in samples from age-matched control mice. The online version contains supplementary material available at 10.1186/s13195-021-00920-6.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage

  • Franco, R.
  • Villa, M.
  • Morales, Paula
  • Reyes-Resina, I.
  • Gutiérrez-Rodríguez, Ana
  • Jiménez, J.
  • Jagerovic, Nadine
  • Martínez-Orgado, José
  • Navarro, Gemma
Preclinical work shows cannabidiol as a promising drug to manage neonatal hypoxic-ischemic brain damage (NHIBD). The molecular mechanism is not well defined but the beneficial effects of this phytocannabinoid are blocked by antagonists of both cannabinoid CB (CB R) and serotonin 5-HT (5-HT1AR) receptors that, in addition, may form heteromers in a heterologous expression system. Using bioluminescence energy transfer, we have shown a direct interaction of the two receptors that leads to a particular signaling in a heterologous system. A property attributed to the heteromer, namely cross-antagonism, was found in primary cultures of neurons thus indicating the occurrence of the receptor heteromer in the CNS. Oxygen-glucose deprivation to neurons led to an increase of CB R-mediated signaling and an upregulation of CB -5-HT heteroreceptor complex expression. In situ proximity ligation assays in brain cortical sections were performed to compare the expression of CB -5-HT complexes in rat E20 fetuses and at different postnatal days. The expression, which is elevated in fetus and shortly after birth, was sharply reduced at later ages (even at P7). The expression of heteromer receptors was more marked in a model of NHIBD and, remarkably, the drop in expression was significantly delayed with respect to controls. These results indicate that CB -5-HT heteroreceptor complex may be considered as a target in the therapy of the NHIBD., This work was supported by grant 201413-30 from: Fundació la Marató de TV3, by grants from the Ministry MINECO/FEDER: SAF2017- 84117-R, SAF2015-68580-C2-2-R and FIS- PI1600629 from the Carlos III Research Institute (ISCiii) according to the Spanish Plan for R+D+I 2008–2011 and the State Plan for Scientific and Technical Research and Innovation 2013–2016, with co-funding from the European Regional Development Funds (FEDER)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor

  • Morales, Paula
  • Navarro, Gemma
  • Gómez-Autet, Marc
  • Redondo, Laura
  • Fernández-Ruiz, Javier
  • Pérez-Benito, Laura
  • Cordomí, Arnau
  • Pardo, Leonardo
  • Franco, Rafael
  • Jagerovic, Nadine
Single chemical entities with potential to simultaneously interact with two binding sites are emerging strategies in medicinal chemistry. We have designed, synthesized and functionally characterized the first bitopic ligands for the CB2 receptor. These compounds selectively target CB2 versus CB1 receptors. Their binding mode was studied by molecular dynamic simulations and site¿directed mutagenesis., This work was supported by the MICIU/FEDER (RTI2018- 095544-B-I00, PID2019-109240RB-I00, SAF2017-84117-R), and by the CSIC (PIE-201580E033). P.M. is grateful to the CM program “Atraccijn de Talento Investigador” number 2018-T2/ BMD-1081.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB2 Receptors

  • Franco, Rafael
  • Morales, Paula
  • Navarro, Gemma
  • Jagerovic, Nadine
  • Reyes-Resina, Irene
The classical terms agonists and antagonists for G protein coupled receptors (GPCRs) have often become misleading. Even the biased agonism concept does not describe all the possibilities already demonstrated for GPCRs. The cannabinoid CB receptor (CBR) emerged as a promising target for a variety of diseases. Reasons for such huge potential are centered around the way drugs sit in the orthosteric and/or exosites of the receptor. On the one hand, a given drug in a specific CBR conformation leads to a signaling cascade that differs qualitatively and/or quantitatively from that triggered by another drug. On the other hand, a given drug may lead to different signaling outputs in two different tissues (or cell contexts) in which the conformation of the receptor is affected by allosteric effects derived from interactions with other proteins or with membrane lipids. This highlights the pharmacological complexity of this receptor and the need to further unravel the binding mode of CBR ligands in order to fine-tune signaling effects and therapeutic propositions., This work was partially supported by AARFD-17-503612 grant of the US Alzheimer’s Association and by grants SAF 2017-84117-R, RTI 2018-094204-B-I00, RTI 2018-095544-B-I00 and PID 2020-113430RB-I00 funded by Spanish MCIN/AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe”, by the “European Union” or by the “European Union Next Generation EU/PRTR”. PM is a postdoctoral fellow supported by the Juan de la Cierva Programme-MICIU (IJC 2019-042182-I). The research group of the University of Barcelona is considered of excellence (grup consolidat #2017 SGR 1497) by the Regional Catalonian Government, which does not provide any specific funding for reagents or for payment of services or Open Access fees, Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Identification of the ghrelin and cannabinoid CB2 receptor heteromer functionality and marked upregulation in striatal neurons from offspring of mice under a high-fat diet

  • Lillo, Jaume
  • Lillo, Alejandro
  • Zafra, David A.
  • Miralpeix Monclús, Cristina
  • Rivas-Santisteban, Rafael
  • Casals i Farré, Núria
  • Navarro, Gemma
  • Franco, Rafael
This work was partially supported by the AARFD-17-503612 grant the US Alzheimer’s Association, and by grants SAF2017-84117-R and PID2020-113430RB-I00 from the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU; or equivalent) and Spanish Agencia Estatal de Investigación (AEI); they include UE FEDER funds., Cannabinoids have been reported as orexigenic, i.e., as promoting food intake that, among others, is controlled by the so-called “hunger” hormone, ghrelin. The aim of this paper was to look for functional and/or molecular interactions between ghrelin GHSR1a and cannabinoid CB2 receptors at the central nervous system (CNS) level. In a heterologous system we identified CB2-GHSR1a receptor complexes with a particular heteromer print consisting of impairment of CB2 receptor/Gi-mediated signaling. The blockade was due to allosteric interactions within the heteromeric complex as it was reverted by antagonists of the GHSR1a receptor. Cannabinoids acting on the CB2 receptor did not affect cytosolic increases of calcium ions induced by ghrelin acting on the GHSR1a receptor. In situ proximity ligation imaging assays confirmed the expression of CB2-GHSR1a receptor complexes in both heterologous cells and primary striatal neurons. We tested heteromer expression in neurons from offspring of high-fat-diet mouse mothers as they have more risk to be obese. Interestingly, there was a marked upregulation of those complexes in striatal neurons from siblings of pregnant female mice under a high-fat diet., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

N -Methyl--Aspartate Receptor Link to the MAP Kinase Pathway in Cortical and Hippocampal Neurons and Microglia Is Dependent on Calcium Sensors and Is Blocked by α-Synuclein, Tau, and Phospho-Tau in Non-transgenic and Transgenic APP Mice

  • Franco, Rafael|||0000-0003-2549-4919
  • Aguinaga Andrés, David|||0000-0003-2506-7204
  • Reyes Resina, Irene|||0000-0003-2077-2537
  • Canela, Enric I.|||0000-0003-4992-7440
  • Lillo Jové, Jaume|||0000-0001-7712-0850
  • Tarutani, Airi|||0000-0003-3835-9070
  • Hasegawa, Masato
  • del Ser Badia, Anna|||0000-0003-1142-1989
  • del Rio, José A.
  • Kreutz, Michael R.
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
N -methyl--aspartate receptors (NMDARs) respond to glutamate to allow the influx of calcium ions and the signaling to the mitogen-activated protein kinase (MAPK) cascade. Both MAPK- and Ca 2+ -mediated events are important for both neurotransmission and neural cell function and fate. Using a heterologous expression system, we demonstrate that NMDAR may interact with the EF-hand calcium-binding proteins calmodulin, calneuron-1, and NCS1 but not with caldendrin. NMDARs were present in primary cultures of both neurons and microglia from cortex and hippocampus. Calmodulin in microglia, and calmodulin and NCS1 in neurons, are necessary for NMDA-induced MAP kinase pathway activation. Remarkably, signaling to the MAP kinase pathway was blunted in primary cultures of cortical and hippocampal neurons and microglia from wild-type animals by proteins involved in neurodegenerative diseases: α-synuclein, Tau, and p-Tau. A similar blockade by pathogenic proteins was found using samples from the APP transgenic Alzheimer's disease model. Interestingly, a very marked increase in NMDAR-NCS1 complexes was identified in neurons and a marked increase of both NMDAR-NCS1 and NMDAR-CaM complexes was identified in microglia from the transgenic mice. The results show that α-synuclein, Tau, and p-Tau disrupt the signaling of NMDAR to the MAPK pathway and that calcium sensors are important for NMDAR function both in neurons and microglia. Finally, it should be noted that the expression of receptor-calcium sensor complexes, specially those involving NCS1, is altered in neural cells from APP mouse embryos/pups.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB Receptor

  • Morales, Paula|||0000-0002-6209-8600
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
  • Gómez-Autet, Marc|||0000-0002-6133-988X
  • Redondo, Laura
  • Fernández-Ruiz, Javier|||0000-0002-4490-0604
  • Pérez-Benito, Laura|||0000-0001-9607-9048
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Franco, Rafael|||0000-0003-2549-4919
  • Jagerovic, Nadine|||0000-0003-2642-6969
Single chemical entities with potential to simultaneously interact with two binding sites are emerging strategies in medicinal chemistry. We have designed, synthesized and functionally characterized the first bitopic ligands for the CB receptor. These compounds selectively target CB versus CB receptors. Their binding mode was studied by molecular dynamic simulations and site-directed mutagenesis. Single chemical entities with potential to simultaneously interact with two binding sites are emerging strategies in GPCR pharmacology. We present herein the design, synthesis and functional characterization of the first bitopic ligands for the CB receptor. Molecular understanding of the binding mode was guided by molecular dynamic simulations and site-directed mutagenesis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Adenosine A2A Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer's Disease

  • Franco, Rafael|||0000-0003-2549-4919
  • Rivas Santisteban, Rafael|||0000-0002-2078-6819
  • Casanovas, Mireia
  • Lillo, Alejandro
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
(1) Background. N-methyl d-aspartate (NMDA) ionotropic glutamate receptor (NMDAR), which is one of the main targets to combat Alzheimer's disease (AD), is expressed in both neurons and glial cells. The aim of this paper was to assess whether the adenosine A2A receptor (A2AR), which is a target in neurodegeneration, may affect NMDAR functionality. (2) Methods. Immuno-histo/cytochemical, biophysical, biochemical and signaling assays were performed in a heterologous cell expression system and in primary cultures of neurons and microglia (resting and activated) from control and the APPSw,Ind transgenic mice. (3) Results. On the one hand, NMDA and A2A receptors were able to physically interact forming complexes, mainly in microglia. Furthermore, the amount of complexes was markedly enhanced in activated microglia. On the other hand, the interaction resulted in a novel functional entity that displayed a cross-antagonism, that could be useful to prevent the exacerbation of NMDAR function by using A2AR antagonists. Interestingly, the amount of complexes was markedly higher in the hippocampal cells from the APPSw,Ind than from the control mice. In neurons, the number of complexes was lesser, probably due to NMDAR not interacting with the A2AR. However, the activation of the A2AR receptors resulted in higher NMDAR functionality in neurons, probably by indirect mechanisms. (4) Conclusions. A2AR antagonists such as istradefylline, which is already approved for Parkinson's disease (Nouriast® in Japan and Nourianz® in the US), have potential to afford neuroprotection in AD in a synergistic-like fashion. i.e., via both neurons and microglia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Design of negative and positive allosteric modulators of the cannabinoid CB2 Receptor derived from the natural product cannabidiol

  • Navarro Brugal, Gemma|||0000-0003-4654-0873
  • Gonzalez, Angel|||0000-0002-2284-8307
  • Sánchez-Morales, Adrià|||0000-0002-8692-0988
  • Casajuana-Martin, Nil|||0000-0002-9007-274X
  • Gómez-Ventura, Marc
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Busqué, Félix|||0000-0001-7566-4264
  • Alibés, Ramon|||0000-0002-7997-2691
  • Pardo Carrasco, Leonardo|||0000-0003-1778-7420
  • Franco, Rafael|||0000-0003-2549-4919
Cannabidiol (CBD), the second most abundant of the active compounds found in the Cannabis sativa plant, is of increasing interest because it is approved for human use and is neither euphorizing nor addictive. Here, we design and synthesize novel compounds taking into account that CBD is both a partial agonist, when it binds to the orthosteric site, and a negative allosteric modulator, when it binds to the allosteric site of the cannabinoid CB2 receptor. Molecular dynamic simulations and site-directed mutagenesis studies have identified the allosteric site near the receptor entrance. This knowledge has permitted to perform structure-guided design of negative and positive allosteric modulators of the CB2 receptor with potential therapeutic utility.